Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Bio-Thera submits IND for Phase I trial of Trop2 positive cancer drug

Histopathology of gastric adenocarcinoma representing a signet ring cell variant. Credit: KGH.



  • Bio-Thera Solutions

Go Top